ClearPoint Neuro (CLPT) Stock: Buy, Sell, or Hold?
CLPT - ClearPoint Neuro, Inc. Common Stock
$9.04
-0.10 (-1.09%)
▼
5d:
-1.42%
30d:
-39.04%
90d:
-37.78%
HOLD
LOW Confidence
Analysis Updated: Oct 26, 2026 12:00 AM ET
Earnings: Oct 28, 2026
TODAY
Get Alerted When CLPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CLPT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CLPT is currently trading at $9.04, which is considered oversold relative to its 30-day fair value range of $9.17 to $13.58.
Technical Outlook: Technically, CLPT is in a strong downtrend. The price is currently testing key support at $8.91. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CLPT scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $23.50 (+160.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLPT is in a strong downtrend. The price is currently testing key support at $8.91. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CLPT scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $23.50 (+160.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.17 -
$13.58
Company Quality Score
57/100
(HOLD)
Options IV Signal
17th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
95.8%
Protect Your Profits
Holding CLPT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 17th percentile)
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 160.0% below Wall St target ($23.50)
- CAUTION: Bottoming setup, but lagging the sector by 31% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$9.17 -
$13.58
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.09
(12.1%)
Support & Resistance Levels
Support Level
$8.91
Resistance Level
$10.17
Current Trend
Strong Downtrend
Technical data as of
Oct 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.56
Wall Street Target
$23.50
(+160.0%)
Revenue Growth (YoY)
18.1%
Profit Margin
-81.8%
Share & Embed Analysis
Last updated: October 27, 2026 1:04 AM ET
Data refreshes hourly during market hours. Next update: 2:04 AM
Data refreshes hourly during market hours. Next update: 2:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$101 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 46 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 52 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 35 SELL |
Advanced CLPT Option Strategies
Professional options setups generated by AI based on today's CLPT price and gamma walls.
